drugset
drugset / Trial / NCT07219017

A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants

NCT07219017 ↗

Phase 1 Completed 8 enrolled AbbVie
NaSingle-groupOpen-labelBasic science

Summary

This study is to assess the mass balance of oral ABBV-1354 in healthy adult male participants.

Timeline

Start
2025-10-15
Primary completion
2025-12-09
Completion
2025-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Icalcaprant Small molecule — Oral

Indications

No indication recorded.